AlphaLens

TERMINAL

ANALYSIS

Heatmap Stock Lists AlphaBrain Compare Track Record News Rumor Radar Calendar Macro Leaderboard ETF X-Ray Learn

MY SPACE

Dashboard Watchlist Portfolio Achievements Settings

QUICK ACCESS

AAPLApple MSFTMicrosoft NVDANVIDIA GOOGLAlphabet AMZNAmazon TSLATesla

Home Screener Watchlist Account

v12

TICKER Dashboard Screener Macro

UTC ●

LOADING MARKET DATA… │ UTC ●

Loading page…

Screener·Stocks·Lists·Heatmap·Top Picks·Deep-Dives·AlphaBrain·Track Record·Accountability·News·Rumor Radar·Compare·Learn·Free SEC Filings·Pricing·FAQ·Terms·Privacy

AlphaLens provides algorithmic financial data and pre-computed AI analysis for educational and informational purposes only. AlphaScore™, TSI™, EQS™, AlphaMomentum™, Close-vs-Gap Pressure, CER™, Volatility Regime™, Earnings Execution™, Macro Regime Detector™, Portfolio Health Engine™, and Similarity Engine™ are proprietary mathematical algorithms. No output constitutes investment advice or a guarantee of future performance. Conduct independent research. Consult a licensed financial advisor.

Medline Inc. (MDLN)

Medline Inc.

Healthcare

$36.26

+1.45%

nightly snapshot · 10/11/2026

ALPHASCORE™ · C · Neutral

ALPHASCORE

/ 100

NEUTRAL

▲ 0 · 30D

KEY FUNDAMENTALS

P/E90.6

ROE10.8%

NET MARGIN4.1%

GROSS MARGIN26.4%

MKT CAP$48.79B

loading full analysis…

DAILY BRIEF

Medline Inc. records an AlphaScore of 46/100 as of October 11, 2026. Important metrics include a revenue growth of 11.47% and a debt-to-equity ratio of 1.17. A notable strength is its strong revenue growth rate, while a primary risk is its low net margin of 4.08%.

Written 11/10/2026, 00:32:50 UTC · Snapshot 11/10/2026